Clinical Trial Update: Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of botulinum toxin for glabellar frown lines has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glabellar Frown Lines

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Galderma R&D | Conditions: Glabellar Frown Lines | Phase 2 | Status: COMPLETED